Ursodeoxycholic acid is a bile acid produced by the liver that helps digest and absorb fats and fat-soluble vitamins. It is used as a prescription drug to treat liver problems such as primary biliary cholangitis (PBC). It solubilizes cholesterol in bile and may help improve bile flow. Ursodeoxycholic acid is available as a generic medication and prescribed to dissolve gallstones made of cholesterol. It helps in preventing gallstones from forming and dissolving small gallstones that are already present. It comes in immediate-release capsule form to be taken by mouth.

The ursodeoxycholic acid market is witnessing high growth due to rising prevalence of biliary and liver diseases and expanding applications of ursodeoxycholic acid. According to the PBC Foundation, primary biliary cholangitis affects around 1 in 1,000 women. Innovation in drug delivery systems and development of novel analogs of ursodeoxycholic acid with improved efficacy through biotech interventions are also fueling the market growth. Nanotechnology-enabled formulations that offer targeted release are being explored. Companies are investing in R&D to develop newer ursodeoxycholic acid formulations having applications beyond liver diseases.
Increasing disease prevalence has been a key factor propelling growth of the primary sclerosing cholangitis market. According to the American College of Gastroenterology, the prevalence of PSC has doubled in recent decades and ranges from 0 to 16.2 cases per 100,000 adults across the globe. Another study found that PSC was diagnosed in about 1 in 10,000 adults in Western countries as of 2015. Genetic and environmental factors are considered responsible for the rise in PSC cases. While the exact cause remains unknown, early diagnosis and treatment of PSC is crucial to slow disease progression and manage complications like cirrhosis of the liver. This has spurred research into new drugs targeting different disease mechanisms, driving demand in the global primary sclerosing cholangitis market during the forecast period.

The major factor fueling growth of the Ursodeoxycholic Acid includes emphasis on developing sustainable renewable energy solutions to address environmental concerns related to greenhouse gas emissions from coal and natural gas-fired power plants. Rising investments by government bodies and private organizations in research & development as well as deployment of ocean energy projects will boost the ocean power market growth over the forecast period. Growing cognizance regarding the vast untapped ocean power potential particularly in regions with large ocean coastline further supports the market expansion.

Get More Insights On Ursodeoxycholic Acid

About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)